_  A new technology, recently approved by the FDA, allows researchers to detect amyloid plaques that often suggest Alzheimer's disease.  Created by Eli Lilly, Amyvid is a drug that, when used before a PET scan, will highlight amyloid plaque in the brain.  This method is much more preferable for diagnosis than the current method of performing an autopsy.

 


Comments


Comments are closed.